๐๏ธ Verified NIH Record โข Updated 2026-03-15
Trans-pulmonary Biomarkers in Pulmonary Hypertension (NCT01961232)
Examination of Trans-pulmonary Biomarkers in Pulmonary Hypertension: a Potential Step Towards Personalized Therapy
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Vanderbilt University
๐ฉบ Plain-English Summary (8th-Grade Level)
The investigators are testing whether the addition of Pulmonary Hypertension-related biomarkers, measured across the pulmonary circulation, to the standard hemodynamic evaluation for Pulmonary Hypertension will lead to more informed choices of Pulmonary Hypertension therapy and improved patient outcomes.
Who can join: Review the eligibility criteria below.
Location: Vanderbilt University Medical Center โ Nashville, Tennessee
Age range: 18 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Vanderbilt University Medical Center โ Nashville, Tennessee
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pulmonary Hypertension
- Activity Monitoring in Pulmonary Hypertension โ Nashville, Tennessee
- LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF โ Tucson, Arizona
- A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) โ Phoenix, Arizona
- A Study of Mosliciguat in PH-ILD โ Phoenix, Arizona
- Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD โ San Francisco, California
Explore by condition: All Pulmonary Hypertension clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.